MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$666,904
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds received from the febru...
Change in fair market value of d...
Proceeds from issuance of debt
Others
Negative Cash Flow Breakdown
Net loss from continuing operati...
Accrued liabilities and other pa...
Disbursements for the february 2...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
(income) loss from equity method investment
-
0
0
392,677
Income Loss From Equity Method Investments
-
392,677
-
-
Income from equity method investment - lab services mso
-
0
-
-
AIGenerated Polishing
-
94,553
-
-
Corporate Other
-
7,889,483
-
-
Other operating expenses
-
7,984,036
-
-
Interest Expense Nonoperating
-
1,456,694
-
-
Interest expense
-
1,456,694
-
-
Gains Losses On Extinguishment Of Debt
-
-9,076,587
-
-
Loss on extinguishment of debt
-
-9,076,587
-
-
Other income (expense)
-
605,767
-
-
Loss on extinguishment of debt
-
0
0
9,076,587
Net loss from continuing operations
-4,376,680
-17,518,873
-
-
Credit loss provision
-
-
-
1,650,000
Depreciation and amortization of intangible assets
563,158
-38,652
44,335
88,760
Net loss
-
-
-254,268
-15,940,709
Change in straight-line rent receivable
-
-
12,621
-58,586
Amortization of operating lease right-of-use asset
16,398
15,633
15,127
33,628
Rent receivable
-
-
-1,747
6,381
Stock-based compensation and service expense
319,819
393,484
661,280
761,698
Security deposit
-
79
80
17,332
Amortization of debt issuance costs and debt discount
189,417
-18,898
31,339
1,123,971
Distribution of earnings from equity method investment
-
0
0
-
Deferred leasing costs
-
-
23,732
-
Change in fair market value of derivative liability
1,276,889
-66,267
-25,130
-446,816
Deferred leasing costs
-
-
-
15,877
Impairment of laboratory equipment
-
0
-
-
Prepaid expense and other assets
37,854
-162,331
-70,288
254,918
Distribution of earnings from equity method investment
-
-
-
0
Debt modification charge
-
0
-
-
Accrued liabilities and other payables
-796,128
764,819
-235,640
1,220,868
Accrued liabilities and other payables - related parties
-
0
0
0
Operating lease obligation
-15,398
-15,633
-15,127
-33,628
Net cash used in operating activities
-
-
-1,360,735
-3,027,822
Net cash used in operating activities from continuing operations
-2,860,379
-4,580,620
-
-
Improvement of commercial real estate
-
-
35,865
-
Cash acquired on acquisition
-
14,026
-
-
Proceeds from sale of equity method investment
280,500
280,500
693,500
95,000
Payment for equity interest purchase
-
0
0
0
Net cash provided by investing activities from continuing operations
-472,135
-
657,635
95,000
Net cash provided by (used in) investing activities from continuing operations
-
1,083,026
-
-
Proceeds from issuance of convertible debt
-
0
200,000
-
Advance from pending sale of noncontrolling interest in subsidiary
-
0
-100,000
149,972
Proceeds from issuance of convertible preferred stock
-
0
300,000
0
Payments of convertible preferred stock issuance costs
-
0
10,000
-
Proceeds from issuance of bridge loan
-
300,000
-
-
Proceeds from issuance of common stock and warrants
-
0
475,500
-
Payments of offering costs
-
12,051
30,265
22,336
Proceeds from stock subscription liability
-
0
150,000
-
Proceeds from issuance of convertible debt and warrants
-
0
-
-
Payments of convertible debt issuance costs
-
0
0
0
Repayments of bridge loan
250,000
0
-
-
Repayments of convertible debt
200,000
0
0
0
Proceeds from issuance of debt
1,164,000
-
0
-
Payments of debt issuance costs
34,000
-
-
-
Proceeds from equity offering
-
0
0
-
Proceeds received from the february 2026 private offering
3,249,412
-
-
-
Proceeds from stock subscription liability
-
-
-
150,000
Disbursements for equity offering costs
-
0
0
-
Disbursements for the february 2026 private offering costs
492,600
-
-
-
Net cash provided by financing activities from continuing operations
3,436,812
287,949
835,235
277,636
Net cash used in operating activities from discontinued operations
-231,956
-407,434
-
-
Net cash used in investing activities from discontinued operations
-
-35,865
-
-
Net cash flows used in discontinued operations
-231,956
-443,299
-
-
Effect of exchange rate on cash - continuing operations
41,927
-9,691
264
409
Net increase (decrease) in cash
666,904
-26,713
132,399
-2,654,777
Cash - beginning of period
109,091
333,931
2,856,309
-
Cash - end of period
775,995
109,091
333,931
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds received from
the february 2026...
$3,249,412
Proceeds from issuance of
debt
$1,164,000
Net cash provided by
financing activities from...
$3,436,812
something is missing
$752,635
Effect of exchange rate
on cash -...
$41,927
Canceled cashflow
$976,600
Net increase
(decrease) in cash
$666,904
Canceled cashflow
$3,564,470
Disbursements for the february
2026 private...
$492,600
Repayments of bridge loan
$250,000
Repayments of convertible
debt
$200,000
Payments of debt issuance
costs
$34,000
Change in fair market
value of derivative...
$1,276,889
Depreciation and
amortization of intangible...
$563,158
Stock-based compensation
and service expense
$319,819
Amortization of debt issuance
costs and debt...
$189,417
Amortization of operating
lease right-of-use...
$16,398
Proceeds from sale of
equity method...
$280,500
Net cash used in
operating activities from...
-$2,860,379
Net cash provided by
investing activities from...
-$472,135
Net cash flows used
in discontinued...
-$231,956
Canceled cashflow
$2,365,681
Canceled cashflow
$280,500
Net loss from
continuing operations
-$4,376,680
something is missing
-$752,635
Net cash used in
operating activities from...
-$231,956
Accrued liabilities and
other payables
-$796,128
Prepaid expense and
other assets
$37,854
Operating lease
obligation
-$15,398
Buy us a coffee
Avalon GloboCare Corp. (ALBT)
Avalon GloboCare Corp. (ALBT)